Please login to read the full article.
Scrip Regulatory Affairs
Canada consults on proposed changes to clinical trials guideline for drugs
09 November 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU consults on uniform approaches to releasing info from marketing dossiers
- Canada consults on three draft guidances on eCTD drug submissions
- Draft EU regulation sets out uniform conditions for various pharmacovigilance activities
- US FDA consults on new framework for classifying significant drug post-market safety issues
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
